Additionally, the sequential or simultaneous inhibition of KIF11 together with BCL2L1 resulted in high levels of apoptosis in SCLC-A or SCLC-N cells, as well as markedly reduced viability. Here, BCL2L1 is linked to small cell lung carcinoma.